Prophylaxis of Contrast Material–induced Nephropathy in Patients in Intensive Care: Acetylcysteine, Theophylline, or Both? A Randomized Study
- 1 June 2006
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 239 (3), 793-804
- https://doi.org/10.1148/radiol.2393041456
Abstract
Purpose: To prospectively compare the protective effect of acetylcysteine, theophylline, and both agents combined in patients who are admitted to the intensive care unit with at least one risk factor for contrast material–induced nephropathy and who receive at least 100 mL of iodinated contrast medium. Materials and Methods: Institutional ethics review board approval and informed consent were obtained. A total of 91 patients (mean age, 58.5 years ± 14.8 [standard deviation]; 31 women, 60 men; 150 examinations) were admitted to the intensive care unit with at least one risk factor for contrast-induced nephropathy and received either (a) 200 mg theophylline 30 minutes before contrast medium administration (group T), (b) 600 mg acetylcysteine twice daily on the day of and (if possible) the day before the examination (group A), or (c) both agents combined (group AT). The primary endpoint for this study was the incidence of contrast-induced nephropathy (χ2 test). Results: Groups T, A, and AT were comparable with regard to baseline creatinine levels and the amount of contrast medium administered. The incidence of contrast-induced nephropathy in groups T, A, and AT was 2%, 12%, and 4%, respectively, and was significantly lower in group T than in group A (P = .047). There was no significant difference in the incidence of contrast-induced nephropathy between groups A and AT (P = .148) or between groups T and AT (P = .53). For group A, serum creatinine did not change after 12, 24, or 48 hours compared with baseline. Creatinine levels in group T decreased 12 hours (1.19 mg/dL ± 0.58; P = .008) and 48 hours (1.16 mg/dL ± 0.55; P = .034) after contrast material injection compared with baseline (1.25 mg/dL ± 0.61). In group AT, creatinine significantly decreased 24 hours (1.21 mg/dL ± 0.74; P = .003) and 48 hours (1.17 mg/dL ± 0.69; P < .001) after contrast material injection compared with baseline (1.28 mg/dL ± 0.74). Group A had significantly higher maximal increases in creatinine than groups T and AT (P = .014). Conclusion: For prophylaxis of contrast-induced nephropathy in patients who are admitted to the intensive care unit and who receive 100 mL or more of contrast medium, theophylline is superior to acetylcysteine. © RSNA, 2006Keywords
This publication has 45 references indexed in Scilit:
- Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrastCatheterization and Cardiovascular Interventions, 2003
- A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiographyKidney International, 2002
- Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathyCatheterization and Cardiovascular Interventions, 2002
- Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidneyClinical Science, 2000
- Oxidant mechanisms in toxic acute renal failureAmerican Journal of Kidney Diseases, 1997
- Role of adenosine in the renal responses to contrast mediumKidney International, 1996
- Modulation of the Renal Effects of Contrast Media by Endothelium-Derived Nitric Oxide in the RatInvestigative Radiology, 1993
- Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletionKidney International, 1992
- Dosing of contrast material to prevent contrast nephropathy in patients with renal diseaseAmerican Journal Of Medicine, 1989
- Hospital-acquired renal insufficiency: A prospective studyAmerican Journal Of Medicine, 1983